Education
About Us
Working with TipRanks
Follow Us
Gain Therapeutics (GANX)
NASDAQ:GANX
GANX Analyst Ratings
Strong Buy
4 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
GANX Stock 12 Month Forecast
Average Price Target
$7.50
▲(186.26% Upside)
| Highest Price Target$10.00 | Average Price Target$7.50 | Lowest Price Target$5.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Maxim Group
$7
Buy
167.18%
Upside
Reiterated
03/12/26
H.C. Wainwright
$8
Buy
205.34%
Upside
Reiterated
01/12/26
BTIG
$5
Buy
90.84%
Upside
Reiterated
01/06/26
Roth MKM
$6→$10
Buy
281.68%
Upside
Reiterated
12/19/25
Oppenheimer
$8
Buy
205.34%
Upside
Reiterated
10/07/25
Scotiabank
$12
Buy
358.02%
Upside
Reiterated
07/09/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Maxim Group
$7
Buy
167.18%
Upside
Reiterated
03/12/26
H.C. Wainwright
$8
Buy
205.34%
Upside
Reiterated
01/12/26
BTIG
$5
Buy
90.84%
Upside
Reiterated
01/06/26
Roth MKM
$6→$10
Buy
281.68%
Upside
Reiterated
12/19/25
Oppenheimer
$8
Buy
205.34%
Upside
Reiterated
10/07/25
Scotiabank
$12
Buy
358.02%
Upside
Reiterated
07/09/25
Best Analysts Covering Gain Therapeutics
3 Months
xxx
Success Rate
10/19 ratings generated profit
Average Return
+12.38%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 52.63% of your transactions generating a profit, with an average return of +12.38% per trade.
1 Year
Success Rate
10/16 ratings generated profit
Average Return
+21.22%
reiterated a buy rating 7 days ago
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 62.50% of your transactions generating a profit, with an average return of +21.22% per trade.
2 Years
xxx
Success Rate
11/16 ratings generated profit
Average Return
+29.15%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 68.75% of your transactions generating a profit, with an average return of +29.15% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
GANX Analyst Recommendation Trends
Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
14
15
12
8
4
Buy
0
0
0
0
0
Hold
0
1
60
75
74
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
14
16
72
83
78
Each month's total comprises the sum of three months' worth of ratings.
GANX Financial Forecast
GANX Stock Forecast FAQ
What is GANX’s average 12-month price target, according to analysts?
Based on analyst ratings, Gain Therapeutics’s 12-month average price target is 7.50.
What is GANX’s upside potential, based on the analysts’ average price target?
Gain Therapeutics has 186.26% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is GANX a Buy, Sell or Hold?
Gain Therapeutics has a consensus rating of Strong Buy which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
What is Gain Therapeutics’s price target?
The average price target for Gain Therapeutics is 7.50. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $10.00 ,the lowest forecast is $5.00. The average price target represents 186.26% Increase from the current price of $2.62.
The highest analyst price target is $10.00 ,the lowest forecast is $5.00. The average price target represents 186.26% Increase from the current price of $2.62.
What do analysts say about Gain Therapeutics?
Gain Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
How can I buy shares of GANX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.